---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003676"
form_type: "8-K/A"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2025-01-27T23:59:59+00:00"
generated_at: "2026-05-27T09:55:10.863644+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Enveric corrects reverse stock split effective date to January 29, 2025

## Summary
- Reverse stock split of 1-for-15 will begin trading on Nasdaq Capital Market on January 29, 2025 (previously January 27).
- Post-split CUSIP number: 29405E 406; trading symbol remains ENVB.
- Amendment filed solely to correct the effective date; original split approved by board and stockholders.

## SEC filing metadata
- accession: 0001493152-25-003676
- form_type: 8-K/A
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2025-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315225003676/0001493152-25-003676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315225003676/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003676
- JSON: https://secwatch.observer/filing/0001493152-25-003676.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.